Essential Partners’s IGM Biosciences IGMS Stock Holding History
Bought
Maintained
Sold
Other funds holding IGMS
Essential Partners's IGMS Position: Q3 2025 in Review
Essential Partners sold out of IGM Biosciences (IGMS) in Q3 2025, closing a stake of 16 shares — an estimated $18 sold.
Essential Partners first reported a position in IGMS in Q2 2025 and held it in 1 quarter. The position peaked at $18 in Q2 2025. 1 fund tracked by Wall St. Rank holds IGMS as of Q3 2025.
- Essential Partners reported no remaining IGM Biosciences position as of Q3 2025 after selling out during the quarter.
- Essential Partners sold 16 IGM Biosciences shares in Q3 2025, an estimated $18.
- Essential Partners first reported a position in IGM Biosciences in Q2 2025 and held it in 1 quarter.
- Essential Partners's IGM Biosciences position peaked at $18 in Q2 2025.
- 1 fund tracked by Wall St. Rank held IGM Biosciences as of Q3 2025.
Based on Essential Partners's 13F filing for Q3 2025, filed 21 May 2026.